Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Medical News
  3. Surgery

Mucin Gel May Help Disk Herniation Patients After Surgery

ReachMD Healthcare Image
09/19/2024
News Faviconmedicalxpress.com
The in situ gelling Muc-gels intervention following discectomy prevent intervertebral disc degeneration. The introduction of “clickable” functionality onto mucins are achieved by reacting amine-tetrazine (Tz) or amine-norbornene (Nb) with activated carboxylic groups found in mucins. Credit: Advanced Science (2024). DOI: 10.1002/advs.202404496

Researchers at Uppsala University have developed a gel inspired by cow slime for patients suffering from disk herniation. By adding the mucin gel immediately after surgery, it is possible to create a protective barrier around the disks to prevent the immune system from attacking their nucleus pulposus. This keeps the disks intact and reduces the risk of further damage.

"This new approach offers hope for those suffering from back pain caused by disk herniation and may prevent further damage after removing herniated disks, potentially improving the quality of life for the patients," says Hongji Yan, researcher at the Department of Medical Cell Biology at Uppsala University andAIMES (Center for the Advancement of Integrated Medical and Engineering Sciences) at Karolinska Institutet, whose study was published in Advanced Science.

Herniated disks are a common problem that can cause severe pain and impaired function of the spine. Many people need surgical removal of herniated disks to relieve the pressure on the nerves in the spine. After surgery, most patients are treated with anti-inflammatory drugs or steroid injections to manage pain and swelling.

However, as yet there is no treatment that stops the immune system from attacking the leftover disk tissue, which can make the injury worse and cause more pain. This shows a gap in post-surgery care for herniated disks, where new treatments that focus on controlling the immune response could help improve recovery and reduce long-term pain.

Currently, most research focuses on trying to regenerate damaged disks rather than preventing further damage. However, because disks lack blood vessels, have few cells and are subject to constant physical stress, it is very difficult to make these solutions work.

In a new study, researchers explored an innovative solution for post-surgery care aimed at preventing further damage after the surgical removal of herniated disks. They developed a synthetic mucin gel, inspired by the mucus coating of certain parasites, which suppresses immune cell activation at infection sites to prevent immune cell recognition.

When applied to the surgical site, this gel prevents further disk damage by stopping immune cells from attacking the nucleus pulposus of intervertebral disks, thanks to its immune-suppressive properties. In contrast, traditional physical barriers like alginate gels failed to provide this level of protection, as demonstrated in the study.

"This approach could have a major impact on surgical procedures, as a simple injection of mucin gels at the surgical site could improve patient outcomes, reduce the risk of long-term complications, and increase the overall success rate of disk surgery," Yan concludes.

The research was carried out together with groups led by Song Chen and Bin Li at Soochow University, China, and João F. Mano at the University of Aveiro, Portugal.

More information: Huan Wang et al, Preserving the Immune‐Privileged Niche of the Nucleus Pulposus: Safeguarding Intervertebral Discs from Degeneration after Discectomy with Synthetic Mucin Hydrogel Injection, Advanced Science (2024). DOI: 10.1002/advs.202404496

Citation: Mucin gel may help disk herniation patients after surgery (2024, September 16) retrieved 16 September 2024 from https://medicalxpress.com/news/2024-09-mucin-gel-disk-herniation-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Schedule2 Dec 2024